MetLife downgraded to Neutral from Buy at UBS UBS downgraded MetLife based on expectations that mix shift to lower beta Protection segments and the resumption of capital management will take longer than expected. Price target raised to $58 from $56.
News For MET From The Last 14 Days
Check below for free stories on MET the last two weeks.
U.S near to designating MetLife as systemically important, Bloomberg says The U.S. Financial Stability Oversight Council is set to designate MetLife as systematically important and thereby subjecting the insurer to oversight by the Federal Reserve, says Bloomberg. Reference Link